glp-1 and afib Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation Ozempic with AFib: Safety, Heart

Efficacy of lymphatic drainage techniques in sports medicine and rehabilitation: A systematic review

Rotating injection sites helps minimize this effect

Next-Generation Poly-agonists The success of tirzepatide demonstrated the superior efficacy of targeting multiple hormonal pathways

Research categories Explore Key Research Pathways Browse compounds by research focus: metabolic, skin & tissue, cognitive, and recovery models

These monotherapy results established proof of concept that amylin receptor agonism alone can produce clinically meaningful weight reduction and informed the dose selection of 2.4 mg for the combination product CagriSema